Connect
MJA
MJA

Advances in stroke medicine

Suk Cheng and Toby Richards
Med J Aust 2020; 212 (1): . || doi: 10.5694/mja2.50431
Published online: 13 January 2020

To the Editor: Reperfusion therapies in acute ischaemic stroke have become well recognised in recent years. The article by Campbell1 summarises current practice and addresses the benefits and challenges of several reperfusion therapies, but it misses one key prevention strategy.


  • 1 University College London, London, UK
  • 2 University of Western Australia, Perth, WA


Correspondence: amanda.cheng@nhs.net

Competing interests:

No relevant disclosures.

  • 1. Campbell BC. Advances in stroke medicine. Med J Aust 2019; 210: 367–374. https://www.mja.com.au/journal/2019/210/8/advances-stroke-medicine
  • 2. Cheng SF, Brown MM, Simister RJ, Richards T. Contemporary prevalence of carotid stenosis in patients presenting with ischaemic stroke. Br J Surg 2019; 106: 872–878.
  • 3. Momjian‐Mayor I, Baron JC. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke 2005; 36: 567–577.
  • 4. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475–1482.
  • 5. Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2017; (6): CD001081.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.